Author: Caillard, Sophie; Chavarot, Nathalie; Francois, Hélène; Matignon, Marie; Greze, Clarisse; Kamar, Nassim; Gatault, Philippe; Thaunat, Olivier; Legris, Tristan; Frimat, Luc; Westeel, Pierre Francois; Goutaudier, Valentin; Snanoudj, Renaud; Colosio, Charlotte; Sicard, Antoine; Bertrand, Dominique; Mousson, Christiane; Bamoulid, Jamal; Masset, Christophe; Thierry, Antoine; Couzi, Lionel; Chemouny, Jonathan M.; Duveau, Agnes; Moal, Valerie; Blancho, Gilles; Grimbert, Philippe; Durrbach, Antoine; Moulin, Bruno; Anglicheau, Dany; Ruch, Yvon; Kaeuffer, Charlotte; Benotmane, Ilies; Solis, Morgane; Le Meur, Yannick; Hazzan, Marc; Danion, Francois
Title: Is Covidâ€19 infection more severe in kidney transplant recipients? Cord-id: e7k4932k Document date: 2020_12_1
ID: e7k4932k
Snippet: There are no studies which have compared the risk of severe Covidâ€19 and related mortality between transplant recipients and nonâ€transplant patients. We enrolled two groups of patients hospitalized for Covidâ€19, i.e., kidney transplant recipients from the French Registry of Solid Organ Transplant (n=306) and a singleâ€center cohort of nonâ€transplant patients (n=795). An analysis was performed among subgroups matched for age and risk factors for severe Covidâ€19 or mortality. Severe Cov
Document: There are no studies which have compared the risk of severe Covidâ€19 and related mortality between transplant recipients and nonâ€transplant patients. We enrolled two groups of patients hospitalized for Covidâ€19, i.e., kidney transplant recipients from the French Registry of Solid Organ Transplant (n=306) and a singleâ€center cohort of nonâ€transplant patients (n=795). An analysis was performed among subgroups matched for age and risk factors for severe Covidâ€19 or mortality. Severe Covidâ€19 was defined as admission (or transfer) to an intensive care unit, need for mechanical ventilation, or death.Transplant recipients were younger and had more comorbidities compared to nonâ€transplant patients. They presented with higher creatinine levels and developed more episodes of acute kidney injury. After matching, the 30â€day cumulative incidence of severe Covidâ€19 did not differ between KTR and nonâ€transplant patients; however, 30â€day Covidâ€19â€related mortality was significantly higher in KTR (17.9% versus 11.4%, respectively, p=0.038). Age >60 years, cardiovascular disease, dyspnea, fever, lymphopenia, and Câ€reactive protein (CRP) were associated with severe Covidâ€19 in univariate analysis, whereas transplant status and serum creatinine levels were not. Age >60 years, hypertension, cardiovascular disease, diabetes, CRP >60 mg/L, lymphopenia, kidney transplant status (HR=1.55), and creatinine level >115 µmol/L (HR=2.32) were associated with Covidâ€19â€related mortality in univariate analysis. In multivariable analysis, cardiovascular disease, dyspnea, and fever were associated with severe disease, whereas age >60 years, cardiovascular disease, dyspnea, fever, and creatinine level>115 µmol/L retained their independent associations with mortality. Kidney transplant recipients had a higher Covidâ€19â€related mortality compared to nonâ€transplant hospitalized patients.
Search related documents:
Co phrase search for related documents- acute aki kidney injury and admission dyspnea: 1
- acute aki kidney injury and admission renal function: 1, 2, 3, 4
- acute aki kidney injury and admission symptom onset: 1, 2
- acute aki kidney injury and admission symptom onset median time: 1
- acute aki kidney injury and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8
- acute aki kidney injury and low incidence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acute aki kidney injury and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- admission creatinine level and low incidence: 1
- admission dyspnea and lopinavir ritonavir: 1, 2
- admission dyspnea and low incidence: 1
- admission dyspnea and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8
- admission pulmonary involvement and lymphocyte count: 1, 2
- admission symptom onset and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8
- admission symptom onset median time and lymphocyte count: 1
- lopinavir ritonavir and low incidence: 1
- lopinavir ritonavir and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
Co phrase search for related documents, hyperlinks ordered by date